Pharma-Bio Serv
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Pharma-Bio Serv's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 12% to $16,976,856. The net income raised on $1,310,180 and profit margin reached 8%. Total operating expenses were $3,949,000.

Profit Margin

Pharma-Bio Serv, Inc. (OTC:PBSV): Profit margin
2014 27.55M 2.41M 8.76%
2015 23.38M 1.62M 6.95%
2016 19.53M -256.57K -1.31%
2017 15.57M -1.41M -9.08%
2018 17.79M 1.27M 7.19%
2019 19.50M 2.08M 10.7%
2020 21.56M 2.05M 9.51%
2021 20.11M -2.08M -10.39%
2022 19.39M 1.00M 5.19%
2023 16.97M 1.31M 7.72%

PBSV Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
16.97M19.39M20.11M21.56M19.50M17.79M15.57M19.53M23.38M27.55M
Cost of revenue
11.91M14.51M14.75M14.89M13.33M12.11M11.96M13.75M15.90M18.58M
Gross profit
5.06M4.88M5.35M6.66M6.17M5.68M3.61M5.78M7.48M8.97M
Operating exp.
Research and development
0000000000
Selling and marketing
0000000000
Total operating expenses
3.94M3.70M9.21M4.44M4.47M4.59M5.03M5.87M5.70M6.10M
Operating income
1.11M1.17M-3.85M2.22M1.69M1.08M-1.42M-91.75K1.78M2.86M
Other income (expenses), net
570.07K13.41K1.97M64.46K526.56K435.52K43.75K-111.98K11.46K14.02K
Income before tax
1.68M1.18M-1.87M2.29M2.22M1.52M-1.41M-203.74K1.79M2.87M
Income tax expense
377.30K181.67K213.24K239.08K135.99K2.78M3.86K52.83K167.98K464.52K
Net income
1.31M1.00M-2.08M2.05M2.08M1.27M-1.41M-256.57K1.62M2.41M
Earnings per share
Basic EPS
0.050.04-0.090.080.090.05-0.06-0.010.070.11
Diluted EPS
0.050.04-0.090.080.090.05-0.06-0.010.060.1
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source